mail
Print view
 
 

CAR-T Cell Therapy Congress USA 2018

Evvnt Promotion / evvnt
Archive
-
20.03.2018 - 22.03.2018  Hilton Boston Dedham Hotel, 25 Allied Drive, Dedham MA 02026, USA
Time: 8:00 am to 5:00 pm
 
Conference themes
CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematologic malignancies…is CAR-T therapy what we've been waiting for?

Join 25+ thought-leaders from biotech, big pharma, academia and the wider service community on 20th - 22nd March 2018 to address the challenges and opportunities of CAR-T therapies.
Professional congress organizer (PCO)
Kisaco Research
Notes
Speakers: Venrock, Adaptimmune, Living Pharma, Dana Farber Innovations, Penn Center Innovation, ZioPharm, Merck KGaA, GSK, TCR2, Juno Therapeutics, Bellicum Pharmaceuticals, Moffitt Cancer Center, Draper Lab, Fate Therapeutics, Cellectis and more...
 

Enquiries and Registration:

Booking: https://go.evvnt.com/190525-2?pid=4832
Mr. Borja Monreal Tames
 
Categories
Clinical Research, Immunology, Internal Medicine, Oncology
Languages
English
Congress fees
USD 799,00
(ACADEMIC & NOT-FOR-PROFIT | 2 DAY CONFERENCE: USD 799 BIOPHARMA & BIOTECH | 2 DAY CONFERENCE: USD 1699 SERVICE PROVIDER | 2 DAY CONFERENCE: USD 1899 COMMERCIALIZATION DAY ONLY: USD 1399)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Anästhesie in Entwicklungsländern e. V.newTreeCharité International AcademyÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzAGEM - Arbeitsgemeinschaft Ethnologie und MedizinCenter of ExcellenceHilfswerk Austria